abstract |
The invention relates to methods for determining the risk of developing neoplasia in tissue, preferably anogenital tissue, that has no histopathological evidence of neoplasia. The method is based on the determination of the methylation state of genomic DNA sequences associated with the ZNF671, ZNF154 genes. ZNF776, ASTN1, BRINP2, DLX1, METAP1D and / or DLX2. |